These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16200776)

  • 1. [Expression of type I and type II 5alpha-reductase isoenzymes in prostate cancer tissues].
    Ye L; Zhang Y; Fang Z
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1504-7. PubMed ID: 16200776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and significance of steroid 5alpha-reductase isoenzymes in benign hyperplastic prostate tissues].
    Ye LF; Zhang YF; Fang ZJ; Ding Q; Yao MS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1296-9. PubMed ID: 12930680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of 5alpha-reductase type 1 and type 2 are increased in localized high grade compared to low grade prostate cancer.
    Thomas LN; Douglas RC; Lazier CB; Gupta R; Norman RW; Murphy PR; Rittmaster RS; Too CK
    J Urol; 2008 Jan; 179(1):147-51. PubMed ID: 17997435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization by in situ hybridization of steroid 5alpha-reductase isozyme gene expression in the human prostate and preputial skin.
    Pelletier G; Luu-The V; Huang XF; Lapointe H; Labrie F
    J Urol; 1998 Aug; 160(2):577-82. PubMed ID: 9679931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a quantitative RT-PCR method to study 5alpha-reductase mRNA isozymes in rat prostate in different androgen status.
    Torres JM; Ruiz E; Ortega E
    Prostate; 2003 Jun; 56(1):74-9. PubMed ID: 12746849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5alpha-reductase isozymes and androgen actions in the prostate.
    Zhu YS; Imperato-McGinley JL
    Ann N Y Acad Sci; 2009 Feb; 1155():43-56. PubMed ID: 19250191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis.
    Habib FK; Ross M; Bayne CW; Bollina P; Grigor K; Chapman K
    Clin Cancer Res; 2003 May; 9(5):1815-9. PubMed ID: 12738739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer.
    Titus MA; Gregory CW; Ford OH; Schell MJ; Maygarden SJ; Mohler JL
    Clin Cancer Res; 2005 Jun; 11(12):4365-71. PubMed ID: 15958619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells.
    Lou YR; Murtola T; Tuohimaa P
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):151-7. PubMed ID: 15862960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
    Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB
    J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.
    Thomas LN; Douglas RC; Lazier CB; Too CK; Rittmaster RS; Tindall DJ
    Eur Urol; 2008 Feb; 53(2):244-52. PubMed ID: 18006217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
    Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
    J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of somatic steroid 5alpha-reductase (SRD5A2) mutations in human prostate cancer tissue.
    Makridakis N; Akalu A; Reichardt JK
    Oncogene; 2004 Sep; 23(44):7399-405. PubMed ID: 15326487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
    Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Messenger RNA levels and enzyme activities of 5 alpha-reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue.
    Shirakawa T; Okada H; Acharya B; Zhang Z; Hinata N; Wada Y; Uji T; Kamidono S; Gotoh A
    Prostate; 2004 Jan; 58(1):33-40. PubMed ID: 14673950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
    Rittmaster RS
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
    Bonkhoff H; Stein U; Aumüller G; Remberger K
    Prostate; 1996 Oct; 29(4):261-7. PubMed ID: 8876709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386.
    Festuccia C; Gravina GL; Muzi P; Pomante R; Angelucci A; Vicentini C; Bologna M
    J Urol; 2008 Jul; 180(1):367-72. PubMed ID: 18499161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of 5 alpha-reductase type 1 increases sensitivity of prostate cancer cells to low concentrations of testosterone.
    Thomas LN; Douglas RC; Rittmaster RS; Too CK
    Prostate; 2009 May; 69(6):595-602. PubMed ID: 19125422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer.
    Thomas LN; Lazier CB; Gupta R; Norman RW; Troyer DA; O'Brien SP; Rittmaster RS
    Prostate; 2005 May; 63(3):231-9. PubMed ID: 15538746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.